Awake extracorporeal membrane oxygenation patients expanding the horizons
Letter to the Editor

Awake extracorporeal membrane oxygenation patients expanding the horizons

Cyril J. Chacko, Shradha Goyal, Hakeem Yusuff

University Hospitals of Leicester, ECMO program, Glenfield Hospital, Leicester, UK

Correspondence to: Dr. Cyril J. Chacko. University Hospitals of Leicester, ECMO program, Glenfield Hospital, Groby Rd, Leicester, LE3 9QP, UK. Email: cjchacko@yahoo.com.

Comment on: Crotti S, Bottino N, Spinelli E. Spontaneous breathing during veno-venous extracorporeal membrane oxygenation. J Thorac Dis 2018;10:S661-9.


Submitted May 14, 2018. Accepted for publication Jun 01, 2018.

doi: 10.21037/jtd.2018.06.28


Awake extracorporeal membrane oxygenation (ECMO) patients—expanding the horizons

We reviewed with interest the article published by Crotii et al. (1) on spontaneously breathing patients during veno-venous ECMO (VV ECMO).

In our centre we have had experience of patient with near fatal asthma that the authors had not included in their review. We reviewed our data from January 2014 to October 2017. We had a total of 34 patients with near fatal asthma. We had extubated 8 patients on ECMO. The mean age was 32 years. The mean ECMO run was 4.25 days with range of 3–6 days. The patients were extubated between days 1–3. Three patients were extubated on day 1, 4 on day 2 and 1 on day 3. One patient was agitated and restless on extubation, but improved with titration of sedation. The treating physicians individually assessed the patients for suitability of extubation. The major contraindication for extubation was hyperactive delirium and agitation. The extubated patients were given supplemental oxygen via nasal cannulae and allowed to breathe spontaneously. Remifentanil and clonidine were the agents of choice to ensure compliance with nursing care and analgesia however not all patients needed this as sometimes regular reassurance was adequate.

VV ECMO has been used as a modality of treatment for asthma (2) refractory to conventional management. Asthma leads to 2–20% of intensive care unit (ICU) admission and the mortality of ventilated patients on ICU is 10–20% (3). In patients with airway hyper reactivity, instrumentation of the airway may evoke bronchospasm (4) and removal of the stimuli could help in recovery of the underlying pathology. Mechanical ventilation in asthma increases the risk of dynamic hyperinflation thereby provoking pulmonary barotrauma, systemic hypotension and arrhythmias (5). The advantage of awake and cooperative patient on ECMO, minimizes these adverse effects of mechanical ventilation, improves patient’s compliance with physiotherapy and rehabilitation. It also minimizes the duration of neuromuscular blockade use (6) that is usually used to improve patient ventilator dyssynchrony. This decreases the risk of critical care associated polyneuromyopathy, and delirium, thereby enhancing patients’ and relatives’ satisfaction. This approach to management of near fatal asthma with the patient awake and spontaneously breathing is a shift from traditional recommendation (3,6,7). The use of VV ECMO would safely facilitate such management strategies in these cases. We would recommend that asthmatic patient should be individually assessed for their suitability for extubation on VVECMO to improve outcomes and patient satisfaction.


Acknowledgements

None.


Footnote

Conflicts of Interest: The authors have no conflicts of interest to declare.


References

  1. Crotti S, Bottino N, Spinelli E. Spontaneous breathing during veno-venous extracorporeal membrane oxygenation. J Thorac Dis 2018;10:S661-9. [Crossref] [PubMed]
  2. Yeo HJ, Kim D, Jeon D, et al. Extracorporeal membrane oxygenation for life-threatening asthma refractory to mechanical ventilation: analysis of the Extracorporeal Life Support Organization registry. Critical Care 2017;21:297. [Crossref] [PubMed]
  3. McFadden ER Jr. Acute severe asthma. Am J Respir Crit Care Med 2003;168:740-59. [Crossref] [PubMed]
  4. Silvanus MT, Groeben H, Peters J. Corticosteroids and inhaled salbutamol in patients with reversible airway obstruction markedly decrease the incidence of bronchospasm after tracheal intubation. Anesthesiology 2004;100:1052-7. [Crossref] [PubMed]
  5. Williams TJ, Tuxen DV, Scheinkestel CD, et al. Risk factors for morbidity in mechanically ventilated patients with acute severe asthma. Am Rev Respir Dis 1992;146:607-15. [Crossref] [PubMed]
  6. Brenner B, Corbridge T, Kazzi A. Intubation and mechanical ventilation of the asthmatic patient in respiratory failure. Proc Am Thorac Soc 2009;6:371-9. [Crossref] [PubMed]
  7. Tobin MJ. Advances in mechanical ventilation. N Engl J Med 2001;344:1986-96. [Crossref] [PubMed]
Cite this article as: Chacko CJ, Goyal S, Yusuff H. Awake extracorporeal membrane oxygenation patients expanding the horizons. J Thorac Dis 2018;10(Suppl 18):S2215-S2216. doi: 10.21037/jtd.2018.06.28

Download Citation